These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10270308)

  • 41. The hospital information system: a physician's perspective.
    Lupovitch A
    Health Prog; 1986 Oct; 67(8):29-31, 62. PubMed ID: 10279006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
    Kile DM; McGrath ME; Schindel LP
    Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The P & T committee: descriptive survey of activities and time requirements.
    Butler CO; Manchester R
    Hosp Formul; 1986 Jan; 21(1):89, 92-5. PubMed ID: 10275083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using DRG data to justify additional clinical pharmacy staff.
    Ibrahim OM; Catania PN; Mergener MA; Catania HF
    Hosp Pharm; 1985 Nov; 20(11):812-7. PubMed ID: 10311306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug information services in Nepal: the changing perspectives.
    Chhetri AK; Palaian S; Mishra P
    Kathmandu Univ Med J (KUMJ); 2008; 6(1):117-21. PubMed ID: 18604128
    [No Abstract]   [Full Text] [Related]  

  • 46. Development of a pocket ruler as a guide to selected drug therapy.
    Wein PJ; Hoffmann RP
    Hosp Pharm; 1985 Oct; 20(10):731-3. PubMed ID: 10274169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of an intravenous infusion admixture nursing reference.
    Rumma ML
    Can J Hosp Pharm; 1981; 34(4):118-20. PubMed ID: 10252989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overestimating clinical functions of distributive staff pharmacists.
    Dillon KR; Caselnova DA
    Hosp Pharm; 1989 Oct; 24(10):849-52. PubMed ID: 10295901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Content and accuracy of abstracting services: clinical perspective.
    Michel DJ
    Hosp Formul; 1988 Jul; 23(7):596-8, 601-3, 607. PubMed ID: 10288149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug information: from education to practice.
    Bernknopf AC; Karpinski JP; McKeever AL; Peak AS; Smith KM; Smith WD; Timpe EM; Ward KE
    Pharmacotherapy; 2009 Mar; 29(3):331-46. PubMed ID: 19249951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Taking the byte: more thoughts about microcomputers.
    Salberg DJ
    Hosp Formul; 1986 Mar; 21(3):351-2. PubMed ID: 10275578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IV push policy: the economic effects of IV drug administration guidelines.
    Hughes TE; Suzuki NT
    Hosp Formul; 1986 Jul; 21(7):793-9, 802. PubMed ID: 10317755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developing an effective P&T Committee, Part I.
    Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
    Hosp Formul; 1985 Jul; 20(7):827-8, 837, 841-3 passim. PubMed ID: 10271920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cephalosporin selection: view from a beleaguered P & T committee member.
    Talley JH
    Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of decision analysis to drug selection for formulary addition.
    Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H
    Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The expanding role of pharmacy and therapeutics committees. The 1990s and beyond.
    Wade WE; Spruill WJ; Taylor AT; Longe RL; Hawkins DW
    Pharmacoeconomics; 1996 Aug; 10(2):123-8. PubMed ID: 10163415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Most P&T committees influence hospital drug-prescribing patterns.
    Hosp Formul; 1977 Jul; 12(7):482. PubMed ID: 10305410
    [No Abstract]   [Full Text] [Related]  

  • 60. Community service in a brown bag.
    Profiles Hosp Mark; 1983; (11):18-23. PubMed ID: 10261245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.